Meta-Analysis of Magnesium Therapy for the Acute Management of Rapid Atrial Fibrillation

American Journal of Cardiology

Volumn 99, Issue 12, 2007, Pages 1726-1732

  Onalan, Orhan ^a   Crystal, Eugene ^a   Daoulah, Amin ^a   Lau, Ching ^a   Crystal, Alexander ^a   Lashevsky, Ilan ^a  

^a SUNNYBROOK RESEARCH INSTITUTE   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

AJMALINE; AMIODARONE; ANTIARRHYTHMIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIGOXIN; DILTIAZEM; MAGNESIUM; MAGNESIUM SULFATE; PLACEBO; VERAPAMIL;

ARTICLE; CLINICAL TRIAL; COMORBIDITY; CONTROLLED CLINICAL TRIAL; DATA BASE; DRUG BLOOD LEVEL; DRUG DOSE REGIMEN; DRUG EFFICACY; DRUG WITHDRAWAL; FLUSHING; FOLLOW UP; HEART ATRIUM FIBRILLATION; HEART FUNCTION TEST; HEART HEMODYNAMICS; HEAT SENSATION; HUMAN; INTENSIVE CARE UNIT; META ANALYSIS; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SIDE EFFECT; SINUS RHYTHM; SYSTEMATIC REVIEW; TREATMENT OUTCOME; TREATMENT RESPONSE;

ATRIAL FIBRILLATION; HUMANS; MAGNESIUM; RANDOMIZED CONTROLLED TRIALS;

EID: 34249878195     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjcard.2007.01.057     Document Type: Article

References (28)

1. Etienne Y., Blanc J.J., Grall J.Y., Boschat J., Gilard M., Houel J.F., and Penther P. Electrophysiological effects of intravenous magnesium sulfate in man. Arch Mal Coeur Vaiss 80 (1987) 1327-1332
2. Rasmussen H.S., and Thomsen P.E. The electrophysiological effects of intravenous magnesium on human sinus node, atrioventricular node, atrium, and ventricle. Clin Cardiol 12 (1989) 85-90
3. Christiansen E.H., Frost L., Andreasen F., Mortensen P., Thomsen P.E., and Pedersen A.K. Dose-related cardiac electrophysiological effects of intravenous magnesium. A double-blind placebo-controlled dose-response study in patients with paroxysmal supraventricular tachycardia. Europace 2 (2000) 320-326
4. Yamamoto H., Bando S., Nishikado A., Nishimura N., Akiyama K., Nouzu N., and Mori H. Electrophysiological effects of magnesium sulfate on human conduction system. Kokyu To Junkan 37 (1989) 77-81
5. DiCarlo Jr. L.A., Morady F., de Buitleir M., Krol R.B., Schurig L., and Annesley T.M. Effects of magnesium sulfate on cardiac conduction and refractoriness in humans. J Am Coll Cardiol 7 (1986) 1356-1362
6. Kulick D.L., Hong R., Ryzen E., Rude R.K., Rubin J.N., Elkayam U., Rahimtoola S.H., and Bhandari A.K. Electrophysiologic effects of intravenous magnesium in patients with normal conduction systems and no clinical evidence of significant cardiac disease. Am Heart J 115 (1988) 367-373
7. Singh R.B., Manmohan M.D., Dube K.P., and Singh V.P. Serum magnesium concentrations in atrial fibrillation. Acta Cardiol 31 (1976) 221-226
8. Eray O., Akca S., Pekdemir M., Eray E., Cete Y., and Oktay C. Magnesium efficacy in magnesium deficient and nondeficient patients with rapid ventricular response atrial fibrillation. Eur J Emerg Med 7 (2000) 287-290
9. DeCarli C., Sprouse G., and LaRosa J.C. Serum magnesium levels in symptomatic atrial fibrillation and their relation to rhythm control by intravenous digoxin. Am J Cardiol 57 (1986) 956-959
10. Aglio L.S., Stanford G.G., Maddi R., Boyd III J.L., Nussbaum S., and Chernow B. Hypomagnesemia is common following cardiac surgery. J Cardiothorac Vasc Anesth 5 (1991) 201-208
11. Miller S., Crystal E., Garfinkle M., Lau C., Lashevsky I., and Connolly S.J. Effects of magnesium on atrial fibrillation after cardiac surgery: a meta-analysis. Heart 91 (2005) 618-623
12. Jadad A.R., Moore R.A., Carroll D., Jenkinson C., Reynolds D.J., Gavaghan D.J., and McQuay H.J. Assessing the quality of reports of randomized clinical trials: is blinding necessary?. Control Clin Trials 17 (1996) 1-12
13. Gullestad L., Birkeland K., Molstad P., Hoyer M.M., Vanberg P., and Kjekshus J. The effect of magnesium versus verapamil on supraventricular arrhythmias. Clin Cardiol 16 (1993) 429-434
14. Brodsky M.A., Orlov M.V., Capparelli E.V., Allen B.J., Iseri L.T., Ginkel M., and Orlov Y.S. Magnesium therapy in new-onset atrial fibrillation. Am J Cardiol 73 (1994) 1227-1229 erratum, Am J Cardiol 1994;74:639
15. Hays J.V., Gilman J.K., and Rubal B.J. Effect of magnesium sulfate on ventricular rate control in atrial fibrillation. Ann Emerg Med 24 (1994) 61-64
16. Joshi P.P., Deshmukh P.K., and Salkar R.G. Efficacy of intravenous magnesium sulphate in supraventricular tachyarrhythmias. J Assoc Physicians India 43 (1995) 529-531
17. Moran J.L., Gallagher J., Peake S.L., Cunningham D.N., Salagaras M., and Leppard P. Parenteral magnesium sulfate versus amiodarone in the therapy of atrial tachyarrhythmias: a prospective, randomized study. Crit Care Med 23 (1995) 1816-1824
18. Walker S., Taylor J., and Harrod R. The acute effects of magnesium in atrial fibrillation and flutter with a rapid ventricular rate. Emergency Med 8 (1996) 207-213
19. Chiladakis J.A., Stathopoulos C., Davlouros P., and Manolis A.S. Intravenous magnesium sulfate versus diltiazem in paroxysmal atrial fibrillation. Int J Cardiol 79 (2001) 287-291
20. Davey M.J., and Teubner D. A randomized controlled trial of magnesium sulfate, in addition to usual care, for rate control in atrial fibrillation. Ann Emerg Med 45 (2005) 347-353
21. Dluzniewski M., Krol J., Kuch M., Syska Suminska J., and Cedro K. Increased efficacy of ajmaline after magnesium administration in the treatment of paroxysmal supraventricular tachyarrhythmias. Kardiol Pol 41 (1994) 201-206
22. Morillo C.A., Klein G.J., Jones D.L., and Guiraudon C.M. Chronic rapid atrial pacing: structural, functional, and electrophysiological characteristics of a new model of sustained atrial fibrillation. Circulation 91 (1995) 1588-1595
23. Wijffels M.C., Kirchhof C.J., Dorland R., and Allessie M.A. Atrial fibrillation begets atrial fibrillation. A study in awake chronically instrumented goats. Circulation 92 (1995) 1954-1968
24. Nattel S., and Ehrlich J.R. Atrial fibrillation. In: Zipes D.P., and Jalife J. (Eds). Cardiac electrophysiology: from cell to bedside (2004), WB Saunders, Philadelphia 512-521
25. Delva P. Magnesium and heart failure. Mol Aspects Med 24 (2003) 79-105
26. Kaye P., and O'Sullivan I. The role of magnesium in the emergency department. Emerg Med J 19 (2002) 288-291
27. Crippa G., Sverzellati E., Giorgi-Pierfranceschi M., and Carrara G.C. Magnesium and cardiovascular drugs: interactions and therapeutic role. Ann Ital Med Int 14 (1999) 40-45
28. Yusuf S., Teo K., and Woods K. Intravenous magnesium in acute myocardial infarction. An effective, safe, simple, and inexpensive intervention. Circulation 87 (1993) 2043-2046